Lewis-Lung (LL/2) - Syngeneic
Rincon Bio performs LL/2 syngeneic models to test efficacy of immunotherapies. Please see below for additional information or to request a quote.
Organism: Mus musculus, mouse / Tissue: lung / Disease: Lewis lung carcinoma
This line is widely used as a model for metastasis and is useful for studying the mechanisms of cancer chemotherapeutic agents. cell line established from the lung of a C57BL mouse bearing a tumor resulting from an implantation of primary Lewis lung carcinoma. Ref
Used as a syngeneic model. Implanted tumor cells create a model in which to test the efficacy of novel immunotherapies
Rincon Bio Growth Curve
WHY WORK WITH
When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices
Most efficacy studies can be initiated within two business days.
We love our clients. We are easy to work with. And we develop a personal interest in our clients and their studies.